is mounjaro a glp 1 receptor agonist Who Candidate For Or GLP-1 Treatment Mounjaro Science: How GIP &
Description
Its all critical, very important and a major contribution to the science, he said
Nausea, diarrhea, and digestive discomfort occur somewhat more frequently with tirzepatide than with semaglutide
doi: 10.3389/fneur.2019.00493
The 2 retatrutide Phase 2 trials are summarized graphically below, links here and here
These specialized immune cells express GLP-1 receptors and when GLP-1(whether from native production or GLP-1 agonists) activates these IELs via GLP-1R it helps to suppress localized T-cell induced inflammation
If Phase 3 trials complete successfully and Lilly submits an NDA in late this year, FDA approval could come by mid to late next year
